Innovus Pharma Announces the Approval of its Product ProstaGorx in Canada for Benign Prostate Hyperplasia (“BPH”)

ProstaGorx is the Ninth Innovus Pharma Product Approved in Canada to Date SAN DIEGO, June 04, 2018 (GLOBE NEWSWIRE) Via OTC PR Wire – Innovus Pharmaceuticals, Inc. ( Innovus Pharma or the Company ) (OTCQB Venture Market:INNV), an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effective over-the-counter medicine and consumer care products to improve men s and women s health and respiratory diseases, today announced the approval by Health Canada of its product ProstaGorx as a Natural Health Product (NPN # 80085717) for The post Innovus Pharma Announces the Approval of its Product ProstaGorx in Canada for Benign Prostate Hyperplasia ( BPH ) appeared first on Public Wire.
http://bit.ly/2xJQHOS